BackAlzamend Neuro Overview

Alzamend Neuro Selling, General & Admin

Selling, General & Admin expenses for ALZN.

Quarterly SG&A Expenses

$919025.00
↑ 55.69% YoY

As of Jan 31, 2026

Annual SG&A Expenses (TTM)

$3.39M
↑ 10.76% YoY

Trailing 12 months ending Jan 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin